GNCA logo

Genocea Biosciences (GNCA) Working Capital

Annual Working Capital

$23.14 M
-$34.09 M-59.57%

December 31, 2021


Summary


Performance

GNCA Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherGNCAbalance sheetmetrics:

Quarterly Working Capital

$6.38 M
-$16.76 M-72.44%

March 31, 2022


Summary


Performance

GNCA Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherGNCAbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

GNCA Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-59.6%-88.9%
3 y3 years+41.7%-65.7%
5 y5 years+957.6%-84.1%

GNCA Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat low-72.4%at low
5 y5-year-59.6%at low-90.4%-50.7%
alltimeall time-74.1%-111.7%-93.1%-142.3%

Genocea Biosciences Working Capital History

DateAnnualQuarterly
Mar 2022
-
$6.38 M(-72.4%)
Dec 2021
$23.14 M(-59.6%)
$23.14 M(-35.6%)
Sep 2021
-
$35.91 M(-25.3%)
Jun 2021
-
$48.08 M(-16.2%)
Mar 2021
-
$57.40 M(+0.3%)
Dec 2020
$57.23 M(+62.1%)
$57.23 M(-14.0%)
Sep 2020
-
$66.51 M(+2015.6%)
Jun 2020
-
$3.14 M(-78.2%)
Mar 2020
-
$14.41 M(-59.2%)
Dec 2019
$35.30 M(+116.3%)
$35.30 M(-4.2%)
Sep 2019
-
$36.85 M(-25.9%)
Jun 2019
-
$49.72 M(+167.8%)
Mar 2019
-
$18.57 M(+13.7%)
Dec 2018
$16.32 M(-705.1%)
$16.32 M(-40.2%)
Sep 2018
-
$27.30 M(-29.7%)
Jun 2018
-
$38.83 M(-15.7%)
Mar 2018
-
$46.04 M(-1806.3%)
Dec 2017
-$2.70 M
-$2.70 M(-132.5%)
DateAnnualQuarterly
Sep 2017
-
$8.30 M(-66.1%)
Jun 2017
-
$24.48 M(-38.8%)
Mar 2017
-
$40.03 M(-25.8%)
Dec 2016
$53.92 M(-39.6%)
$53.92 M(-22.2%)
Sep 2016
-
$69.32 M(-16.6%)
Jun 2016
-
$83.16 M(-10.1%)
Mar 2016
-
$92.47 M(+3.6%)
Dec 2015
$89.23 M(+111.6%)
$89.23 M(-1.0%)
Sep 2015
-
$90.14 M(+30.6%)
Jun 2015
-
$69.00 M(-11.3%)
Mar 2015
-
$77.83 M(+84.6%)
Dec 2014
$42.17 M(+403.1%)
$42.17 M(-7.7%)
Sep 2014
-
$45.67 M(-16.8%)
Jun 2014
-
$54.91 M(-12.0%)
Mar 2014
-
$62.40 M(+644.4%)
Dec 2013
$8.38 M(+5.7%)
$8.38 M(-13.3%)
Sep 2013
-
$9.67 M(+21.9%)
Dec 2012
$7.93 M(+105.9%)
$7.93 M
Dec 2011
$3.85 M
-

FAQ

  • What is Genocea Biosciences annual working capital?
  • What is the all time high annual working capital for Genocea Biosciences?
  • What is Genocea Biosciences annual working capital year-on-year change?
  • What is Genocea Biosciences quarterly working capital?
  • What is the all time high quarterly working capital for Genocea Biosciences?
  • What is Genocea Biosciences quarterly working capital year-on-year change?

What is Genocea Biosciences annual working capital?

The current annual working capital of GNCA is $23.14 M

What is the all time high annual working capital for Genocea Biosciences?

Genocea Biosciences all-time high annual working capital is $89.23 M

What is Genocea Biosciences annual working capital year-on-year change?

Over the past year, GNCA annual working capital has changed by -$34.09 M (-59.57%)

What is Genocea Biosciences quarterly working capital?

The current quarterly working capital of GNCA is $6.38 M

What is the all time high quarterly working capital for Genocea Biosciences?

Genocea Biosciences all-time high quarterly working capital is $92.47 M

What is Genocea Biosciences quarterly working capital year-on-year change?

Over the past year, GNCA quarterly working capital has changed by -$51.02 M (-88.89%)